Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients.

K L WhitcroftN GunderM CuevasP AndrewsS MenzelA HaehnerThomas Hummel

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)

Treatment with intranasal sodium citrate for a period of 2 weeks does not appear to improve quantitative olfactory function in patients with post-infectious impairment, compared to control. It may, however, be beneficial in treating phantosmia, which should be further addressed in future work.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
high resolution
chronic kidney disease
systematic review
prognostic factors
peritoneal dialysis
randomized controlled trial
clinical trial
study protocol
open label
combination therapy